Peripheral T-Cell Lymphoma not otherwise specified with oral manifestation: A Case Report.

  • Alvaro Vigouroux Hospital San Juan de Dios, Santiago, Chile. http://orcid.org/0000-0002-7194-3458
  • Felipe Lillo Servicio de Anatomía patológica, Hospital San Juan de Dios, Santiago, Chile.
  • Francisca Donoso Servicio de Cirugía Maxilofacial, Hospital San Juan de Dios, Santiago, Chile.
DOI: https://doi.org/10.17126/joralres.2020.098

Abstract

Peripheral T-Cell Lymphoma Not Otherwise Specified it is a rare type of Non-Hodgkin t-cells malignant tumor whose oral manifestations are difficult to diagnose. A case of a 48-year-old male with a hemi-maxillary lesion histological and immunohistochemically compatible with Peripheral T-Cell Lymphoma not otherwise specified is presented. A case of a 48-year-old male with a hemi-maxillary lesion histological and immunohistochemically compatible with Peripheral T-Cell Lymphoma not otherwise specified is presented.  The patient treatment consisted of chemotherapy, but after the second cycle, died from immunosuppressive complications. Early stage diagnosis of oral lesions is imperative to avoid aggressive treatment and low overall survival rate of such pathologies.

References

[1]. Silva T, TavaresFerreira C, Boehmer Leite G, de Menezes Pontes J, Antunes H. Oral manifestations of lymphoma: a systematic review. Ecancermedicalscience. 2016;10.

[2]. Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, Advani R, Ghielmini M, Salles GA, Zelenetz AD, Jaffe ES. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127(20):2375-90.

[3]. Weisenburger DD, Savage KJ, Harris NL, Gascoyne RD, Jaffe ES, MacLennan KA, Rüdiger T, Pileri S, Nakamura S, Nathwani B, Campo E, Berger F, Coiffier B, Kim WS, Holte H, Federico M, Au WY, Tobinai K, Armitage JO, Vose JM; International Peripheral T-cell Lymphoma Project. Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma Project. Blood. 2011;117(12):3402-8.

[4]. Park H, McIntosh L, Braschi-Amirfarzan M, Shinagare A, Krajewski K. T-Cell Non-Hodgkin Lymphomas: Spectrum of Disease and the Role of Imaging in the Management of Common Subtypes. Korean J Radiol. 2017;18(1):71.

[5]. Wobser M, Reinartz T, Roth S, Goebeler M, Rosenwald A, Geissinger E. Cutaneous CD8+ Cytotoxic T-Cell Lymphoma Infiltrates: Clinicopathological Correlation and Outcome of 35 Cases. Oncology and Therapy. 2016;4(2):199‐210.

[6]. Federico M, Bellei M, Marcheselli L, Schwartz M, Manni M, Tarantino V, Pileri S, Ko YH, Cabrera ME, Horwitz S, Kim WS, Shustov A, Foss FM, Nagler A, Carson K, Pinter-Brown LC, Montoto S, Spina M, Feldman TA, Lechowicz MJ, Smith SM, Lansigan F, Gabus R, Vose JM, Advani RH; T cell Project Network. Peripheral T cell lymphoma, not otherwise specified (PTCL-NOS). A new prognostic model developed by the International T cell Project Network. Br J Haematol. 2018;181(6):760-9.

[7]. Hildyard C, Shiekh S, Browning J, Collins GP. Toward a Biology-Driven Treatment Strategy for Peripheral T-cell Lymphoma. Clinical Medicine Insights: Blood Disorders. 2017;10:1179545X17705863.

[8]. Bryer E, Henry D. Isolated hypoglossal nerve palsy as a presenting symptom of metastatic peripheral T-cell lymphoma - not otherwise specified (PTCL-NOS): a unique case & a review of the literature. Int J Hematol Oncol. 2018;7(1):IJH03.

[9]. Dos Santos H, Alves C, Almendra Mattos R, Curi D, Leite Ribeiro P, Sarmento V. Peripheral T-cell non-Hodgkin lymphoma manifesting as a primary lesion on the lip: A rare case report. Special Care in Dentistry. 2018;38(6):438‐44.

[10]. Singh A, Bhagat M, Siddiqui A, Thapa S. Peripheral T-cell Lymphoma, Not Otherwise Specified: An Unusual Presentation of a Rare Lymphoma. Cureus. 2019;11(1):e3813.

[11]. Wollina U, Hansel G, Langner D, Koch A, Schönlebe J, Tchernev G. Rapid Evolving Unilateral Indurated Oozing Facial Plaques in a Patient with Head-and-Neck Cancer: Peripheral T-Cell Lymphoma Not Otherwise Specified (NOS). Open Access Maced J Med Sci. 2017;5(4):476-479.

[12]. Shim H, Jang S, Huh J, Yoon D, Suh C, Park C. Cluster Containing More Than 20 CD3-Positive Cells in Bone Marrow Biopsy Is a Candidate Prognostic Indicator in Peripheral T-Cell Lymphoma, Not Otherwise Specified. Annals of Laboratory Medicine. 2019;39(2):200‐204.

[13]. Yi J, Kim S, Kim W. Recent advances in understanding and managing T-cell lymphoma. F1000Research. 2017;6:2123.

[14]. Pai AH, George A, Adiga D, Girisha BS. Peripheral T cell lymphoma: not otherwise specified. Indian J Dermatol. 2015;60(2):215.
Published
2020-12-01
How to Cite
VIGOUROUX, Alvaro; LILLO, Felipe; DONOSO, Francisca. Peripheral T-Cell Lymphoma not otherwise specified with oral manifestation: A Case Report.. Journal of Oral Research, [S.l.], v. 9, n. 6, p. 516-521, dec. 2020. ISSN 0719-2479. Available at: <https://www.joralres.com/index.php/JOralRes/article/view/joralres.2020.098>. Date accessed: 28 sep. 2023. doi: https://doi.org/10.17126/joralres.2020.098.
Citation Formats
Issue
Vol 9 No 6 (2020)
Section
Cases

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. © 2023.